LENZ Therapeutics

LENZ

Börsenwert 130 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Samsara BioCapital Palo Alto, California	28,1 Mio. $	–	–	–
2	2 EcoR1 Capital San Francisco, California	19 Mio. $	+13,7 Mio. $	+589.995	+261 %
3	3 Avidity Partners Management Dallas, Texas	5,23 Mio. $	–	–	–
4	4 Vanguard Group Malvern, Pennsylvania	4,07 Mio. $	+88.196 $	+3.805	+2 %
5	5 Citadel Advisors Miami, Florida	3,95 Mio. $	-276.941 $	-11.948	-7 %
6	6 Fidelity Investments Boston, Massachusetts	3,71 Mio. $	-12,4 Mio. $	-536.662	-77 %
7	7 Tang Capital Management San Diego, California	3,65 Mio. $	–	–	–
8	8 Federated Hermes Pittsburgh, Pennsylvania	3,51 Mio. $	+1.715 $	+74	+0 %
9	9 Prosight Management Dallas, Texas	3,04 Mio. $	+1,85 Mio. $	+80.016	+157 %
10	AG 10 Artal Group Luxembourg	2,32 Mio. $	–	–	–
11	11 Privium Fund Management (UK) London, United Kingdom	2,03 Mio. $	+157.477 $	+6.794	+8 %
12	12 Laurion Capital Management New York	1,9 Mio. $	–	–	–
13	13 BlackRock New York	1,73 Mio. $	+124.587 $	+5.375	+8 %
14	14 Board of Trustees of The Leland Stanford Junior University Redwood City, California	1,52 Mio. $	-807.252 $	-34.827	-35 %
15	15 OUP Management Company Bala Cynwyd, Pennsylvania	1,35 Mio. $	–	–	–
16	16 Renaissance Technologies New York	1,1 Mio. $	-636.075 $	-27.442	-37 %
17	17 Two Sigma Advisers New York	847.264 $	-37.086 $	-1.600	-4 %
18	18 Oasis Management Company Grand Cayman, Cayman Islands	846.939 $	–	–	–
19	19 Geode Capital Management Boston, Massachusetts	805.000 $	+75.053 $	+3.238	+10 %
20	20 GSA Capital Partners London, United Kingdom	712.000 $	+78.785 $	+3.399	+12 %
21	21 Two Sigma Investments New York	691.778 $	-172.057 $	-7.423	-20 %
22	22 Cormorant Asset Management Boston, Massachusetts	662.000 $	–	–	–
23	23 Millennium Management New York	443.000 $	-719.635 $	-31.047	-62 %
24	24 Bridgeway Capital Management Houston, Texas	433.260 $	+56.302 $	+2.429	+15 %
25	25 Man Group London, United Kingdom	371.169 $	+240.296 $	+10.367	+185 %

LENZ Therapeutics LENZ Börsenwert 130 Mio. $

LENZ Therapeutics

LENZ

Börsenwert 130 Mio. $